As of close of business last night, Graphite Bio Inc’s stock clocked out at $3.56, up 4.71% from its previous closing price of $3.40. In other words, the price has increased by $+0.1600 from its previous closing price. On the day, 1341457 shares were traded.
Ratios:
To gain a deeper understanding of GRPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 39.20 and its Current Ratio is at 39.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On February 23, 2023, Cantor Fitzgerald Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $3.
BofA Securities Downgraded its Neutral to Underperform on February 23, 2023, whereas the target price for the stock was revised from $3 to $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRPH now has a Market Capitalization of 197.42M and an Enterprise Value of 13.53M.
Stock Price History:
Over the past 52 weeks, GRPH has reached a high of $4.26, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is 2.9646, while the 200-Day Moving Average is calculated to be 2.6040.
Shares Statistics:
It appears that GRPH traded 240.73K shares on average per day over the past three months and 783.15k shares per day over the past ten days. A total of 58.01M shares are outstanding, with a floating share count of 27.61M. Insiders hold about 52.59% of the company’s shares, while institutions hold 40.38% stake in the company. Shares short for GRPH as of Feb 29, 2024 were 704.04k with a Short Ratio of 2.92, compared to 801.78k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.21% and a Short% of Float of 1.95%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.11, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.4 and -$0.4 for the fiscal current year, implying an average EPS of -$0.4. EPS for the following year is -$0.4, with 1 analysts recommending between -$0.4 and -$0.4.
